| Preoperative chemoradiotherapy for esophageal or junctional cancer P van Hagen, M Hulshof, JJB Van Lanschot, EW Steyerberg, ... New England Journal of Medicine 366 (22), 2074-2084, 2012 | 5841 | 2012 |
| Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial J Shapiro, JJB Van Lanschot, MCCM Hulshof, P van Hagen, ... The lancet oncology 16 (9), 1090-1098, 2015 | 2604 | 2015 |
| Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial SSAY Biere, MI van Berge Henegouwen, KW Maas, L Bonavina, ... The Lancet 379 (9829), 1887-1892, 2012 | 1935 | 2012 |
| Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study D Nepogodiev, A Bhangu, JC Glasbey, E Li, OM Omar, JFF Simoes, ... The Lancet 396 (10243), 27-38, 2020 | 1902 | 2020 |
| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study D Lobo, JM Devys Anaesthesia 77 (1), 110, 2021 | 589* | 2021 |
| Minimally invasive versus open esophageal resection: three-year follow-up of the previously reported randomized controlled trial: the TIME trial J Straatman, N Van Der Wielen, MA Cuesta, F Daams, JR Garcia, ... Annals of surgery 266 (2), 232-236, 2017 | 568 | 2017 |
| Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial BM Eyck, JJB van Lanschot, MCCM Hulshof, BJ van der Wilk, J Shapiro, ... Journal of Clinical Oncology 39 (18), 1995-2004, 2021 | 546 | 2021 |
| Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial A Cats, EPM Jansen, NCT van Grieken, K Sikorska, P Lind, M Nordsmark, ... The lancet oncology 19 (5), 616-628, 2018 | 536 | 2018 |
| Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials V Oppedijk, A van der Gaast, JJB van Lanschot, P van Hagen, R van Os, ... Journal of Clinical Oncology 32 (5), 385-391, 2014 | 531 | 2014 |
| Global burden of oesophageal and gastric cancer by histology and subsite in 2018 M Arnold, J Ferlay, MI van Berge Henegouwen, I Soerjomataram Gut 69 (9), 1564-1571, 2020 | 495 | 2020 |
| Medical liability insurance claims on entry-related complications in laparoscopy J Wind, JEL Cremers, MI van Berge Henegouwen, DJ Gouma, FW Jansen, ... Surgical endoscopy 21, 2094-2099, 2007 | 396 | 2007 |
| Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant MI van Berge Henegouwen, LT De Wit, TM Van Gulik, H Obertop, ... Journal of the American College of Surgeons 185 (1), 18-24, 1997 | 386 | 1997 |
| Delayed gastric emptying after standard pancreaticoduodenectomy versus pylorus-preserving pancreaticoduodenectomy: an analysis of 200 consecutive patients MI van Berge Henegouwen, TM van Gulik, LT DeWit, JH Allema, ... Journal of the American College of Surgeons 185 (4), 373-379, 1997 | 306 | 1997 |
| Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study KN Phoa, RE Pouw, FGI Van Vilsteren, CMT Sondermeijer, FJW Ten Kate, ... Gastroenterology 145 (1), 96-104, 2013 | 294 | 2013 |
| Learning curve and associated morbidity of minimally invasive esophagectomy: a retrospective multicenter study F Van Workum, MHBC Stenstra, GHK Berkelmans, AE Slaman, ... Annals of surgery 269 (1), 88-94, 2019 | 291 | 2019 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 284 | 2021 |
| Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study BJ Noordman, MCW Spaander, R Valkema, BPL Wijnhoven, ... The Lancet Oncology 19 (7), 965-974, 2018 | 279 | 2018 |
| Defining benchmarks for transthoracic esophagectomy: a multicenter analysis of total minimally invasive esophagectomy in low risk patients HM Schmidt, SS Gisbertz, J Moons, I Rouvelas, J Kauppi, A Brown, E Asti, ... Annals of surgery 266 (5), 814-821, 2017 | 262 | 2017 |
| Textbook outcome as a composite measure in oesophagogastric cancer surgery LAD Busweiler, MG Schouwenburg, MI van Berge Henegouwen, ... Journal of British Surgery 104 (6), 742-750, 2017 | 257 | 2017 |
| Perioperative strategy in colonic surgery; LA paroscopy and/or FA st track multimodal management versus standard care (LAFA trial) J Wind, J Hofland, B Preckel, MW Hollmann, PMM Bossuyt, DJ Gouma, ... BMC surgery 6, 1-8, 2006 | 256 | 2006 |